Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Current Pharmaceutical Design|February 10, 2009
Pleiotropic effects of fenofibrateV Tsimihodimos, E Liberopoulos, M ElisafThyroid : Official Journal of the American Thyroid Association|May 13, 1999
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicV Tsimihodimos, E Bairaktari, C Tzallas, et al.Diabetes Research and Clinical Practice|December 27, 2017
Effects of evolving lipid-lowering drugs on carbohydrate metabolismV Tsimihodimos, M ElisafInternational Journal of Clinical Practice|June 4, 2009
Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implicationsV Tsimihodimos, V Kakaidi, M ElisafDiabetes, Obesity & Metabolism|April 12, 2001
Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidismE Liberopoulos, G Miltiadous, M ElisafDiabetes & Metabolism|December 6, 2016
Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysisF Barkas, M Elisaf, V Tsimihodimos, et al.International Angiology : a Journal of the International Union of Angiology|July 13, 2011
Anticoagulant drugs: what is new?A Kei, M Florentin, M Elisaf, et al.The Journal of Infection|January 15, 2004
Enterococcus casseliflavus bacteremia. Case report and literature reviewG Pappas, E Liberopoulos, E Tsianos, et al.International Urology and Nephrology|January 14, 2017
PCSK9 in chronic kidney diseaseP Pavlakou, E Liberopoulos, E Dounousi, et al.Current Vascular Pharmacology|October 18, 2016
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption InhibitionV Tsimihodimos, T D Filippatos, S Filippas-Ntekouan, et al.Pageof 11